Mankind Pharma files DRHP with SEBI
the company’s Initial Public Offering (IPO) comprises an offer for sale of 40,058,884 equity shares of face value Re 1 each by selling shareholders including the promoters and the existing investors
Mankind Pharma has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI), as per a company statement.
The statement also said that the company’s Initial Public Offering (IPO) comprises an offer for sale of 40,058,884 equity shares of face value Re 1 each by selling shareholders including the promoters and the existing investors.
The offer for sale comprises up to 3,705,443 equity shares by Ramesh Juneja; up to 3,505,149 equity shares by Rajeev Juneja; up to 2,804,119 equity shares by Sheetal Arora (“Collectively, The “Promoter Selling Shareholders”); up to 17,405,559 equity shares by Cairnhill CIPEF; up to 2,623,863 equity shares by Cairnhill CGPE; up to 9,964,711 equity shares by Beige and up to 50,000 equity shares by Link Investment Trust (“Collectively, The “Investor Selling Shareholders”), the statement added.